Compass Capital Corp’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$474K Buy
792
+4
+0.5% +$1.92K 0.15% 128
2026
Q1
$371K Buy
788
+17
+2% +$9.23K 0.13% 143
2025
Q4
$416K Buy
771
+30
+4% +$17K 0.16% 123
2025
Q3
$431K Buy
741
+30
+4% +$14K 0.19% 103
2025
Q2
$328K Buy
711
+22
+3% +$9.2K 0.15% 131
2025
Q1
$290K Hold
689
0.15% 144
2024
Q4
$358K Buy
+689
New +$379K 0.14% 140

Other funds holding TMO

Compass Capital Corp's TMO Position: Q2 2026 in Review

Compass Capital Corp increased its Thermo Fisher Scientific (TMO) stake by 0.51% in Q2 2026, buying an estimated $1.92K and bringing the position to 792 shares worth $474K. The position accounts for 0.15% of the portfolio, ranked #128.

Compass Capital Corp first reported a position in TMO in Q4 2024 and has held it in 7 quarters since. 2,609 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Compass Capital Corp held 792 shares of Thermo Fisher Scientific worth $474K as of Q2 2026.
  • Compass Capital Corp bought 4 Thermo Fisher Scientific shares in Q2 2026, an estimated $1.92K.
  • Thermo Fisher Scientific made up 0.15% of Compass Capital Corp's portfolio in Q2 2026, its #128 holding.
  • Compass Capital Corp first reported a position in Thermo Fisher Scientific in Q4 2024 and has held it in 7 quarters since.
  • 2,609 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Compass Capital Corp's 13F filing for Q2 2026, filed 13 Aug 2026.